More
    Guided Solutions - Connecting Talent With Innovation/div>

    GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care

    GE HealthCare (Nasdaq: GEHC) announces the launch of CardioVisio for Atrial Fibrillation (AFib), a digital tool designed to assist clinicians in visualizing longitudinal data...

    New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery

    Researchers Found That Fluid Therapy Guided by Noninvasive, Continuous PVi Reduced Cardiopulmonary Complications and Fluid Administered Masimo (NASDAQ: MASI) announced the findings of a prospective, randomized...

    Anuncia announces first successful implant of ReFlow mini flusher in hydrocephalus patient

    Anuncia Medical has announced the successful first implant of the company’s US Food and Drug Administration (FDA)-cleared ReFlow mini flusher device. Performed on by neurosurgeon Samuel...

    HAPPE Spine Announces First Clinical Use of the INTEGRATE®-C Interbody Fusion System

    HAPPE Spine announces that the first clinical case with the INTEGRATE®-C Interbody Fusion System was completed by co-inventor and neurosurgeon Dr. Stephen Smith, MD, at the...

    DermaSensor reports positive results for skin cancer detection device across multiple skin tones

    DermaSensor announced promising results from a sub-analysis study focusing on skin cancer detection across different skin tones. The sub-analysis came from the company’s DERM-SUCCESS study, which previously...

    Intuitive’s Ion Endoluminal System Used for First Time in the UK

    Clinicians at Royal Brompton Hospital, part of Guy’s and St Thomas’ NHS Foundation Trust, and St Bartholomew’s Hospital are the first in the UK...

    Feasibility study backs Glucotrack implantable CGM

    Glucotrack (Nasdaq:GCK) announced that it completed a feasibility study for its implantable continuous glucose monitor (CGM). Rutherford, New Jersey-based Glucotrack designed its CGM for patients with...

    Suono Bio Reports Encouraging Results From a First in Human (FiH) Study of Its Ultrasound Mediated Drug Delivery Platform

    Suono Bio Inc., the company revolutionizing therapeutic platforms to improve the efficacy and safety of novel medicines, has released encouraging results from the first...

    Cognito Therapeutics Presents New MRI Data Showing Non-Invasive Gamma Stimulation Therapy Reduces Brain Atrophy and Myelin Loss in Alzheimer’s Disease

    White matter plays a critical role in brain function and reducing white matter atrophy and myelin loss may contribute to slowing Alzheimer’s disease progression. Early...

    Latest articles